Search
Now showing items 1-7 of 7
Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies
(2014)
Scabies is found worldwide among people of all groups and ages. It is curable with scabicide medications. This study aimed to compare the efficacy and safety of oral ivermectin vs malathion 0.5% lotion for the treatment ...
Maternal-neonatal outcome in pregnancies with non-obstetric laparotomy during pregnancy
(2014)
In this study maternal and neonatal outcome evaluated in each trimester of pregnancies with non obstetric laparotomies. In this descriptive-analytic study, 100 pregnant women operated during pregnancy were evaluated. Based ...
Leprosy in Iran: An analysis of 195 cases from 1994-2009
(2011)
Objectives: To estimate the prevalence of Leprosy in Azerbaijan, Iran. Methods: A total of 195 new leprosy cases referred to and registered in Bababaghi Center, Azerbaijan, Northwest of Iran from 1994-2009 were studied. ...
Seroepidemiology of toxoplasmosis in childbearing women of Northwest Iran [Sieroepidemiologia della toxoplasmosi in donne in et fertile in Iran nord-occidentale]
(2013)
Toxoplasma gondii causes the most common parasitic infection in the world. Congenital transmission, prenatal mortality and abortion are major problems of T. gondii. Prevalence of toxoplasmosis is high in Iran, especially ...
Treatment of scabies: Comparison of lindane 1% vs permethrin 5%
(2015)
Scabies, whose etiologic agent is Sarcoptes scabiei, is a neglected parasitic disease that is a major public health problem in many resourcepoor regions. Its current therapies include benzyl benzoate, lindane, permethrin, ...
Treatment of solar lentigines with trichloroacetic acid 40% vs. cryotherapy
(2011)
[No abstract available]
The efficacy of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies
(2015)
Human scabies is caused by an infection of the skin by the human itch mite (Sarcoptes scabiei var. hominis). There are different medications for the treatment of scabies. This study aimed at comparing the efficacy and ...